Overlapping Immunohistochemical Features of Adenocarcinoma of the Nonpigmented Ciliary Body Epithelium and Renal Cell Carcinoma.


Journal

American journal of ophthalmology
ISSN: 1879-1891
Titre abrégé: Am J Ophthalmol
Pays: United States
ID NLM: 0370500

Informations de publication

Date de publication:
06 2021
Historique:
received: 16 08 2020
revised: 22 01 2021
accepted: 25 01 2021
pubmed: 3 2 2021
medline: 11 9 2021
entrez: 2 2 2021
Statut: ppublish

Résumé

To find immunohistochemical markers that distinguish adenocarcinoma of the nonpigmented ciliary epithelium (NPCE) from metastatic carcinoma, especially metastatic renal cell carcinoma. Retrospective case series. Three cases of adenocarcinoma of the NPCE were examined histologically with hematoxylin-eosin stain and immunohistochemical stains including vimentin, AE1/AE3, Cam 5.2, CK7, PAX2, PAX8, AMACR, and CAIX. We also reviewed previously reported cases of this tumor. We found that the immunohistochemical profile of adenocarcinoma of the NPCE can overlap with renal cell carcinoma. Both tumors can express vimentin, cytokeratin AE1/AE3, Cam 5.2, PAX2, PAX8, and AMACR. One of the adenocarcinomas of the NPCE in our series also expressed CD10 and the renal cell carcinoma marker (RCC Ma). Carbonic anhydrase IX (CAIX) was not detected in any of the 3 tumors. Adenocarcinomas arising in phthisic eyes can be diagnostically challenging. We have found it particularly difficult to distinguish adenocarcinoma of the NPCE from metastatic carcinoma, especially metastatic clear cell renal cell carcinoma and papillary renal cell carcinoma. Because of the immunophenotypic overlap, most patients will require systemic workup including imaging of the kidneys to be certain of the diagnosis.

Identifiants

pubmed: 33529584
pii: S0002-9394(21)00041-6
doi: 10.1016/j.ajo.2021.01.020
pii:
doi:

Substances chimiques

Biomarkers, Tumor 0
Neoplasm Proteins 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

191-200

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Mehenaz Hanbazazh (M)

From the David G. Cogan Laboratory of Ophthalmic Pathology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: mehenaz_hanbazazh@hotmail.com.

Paula Cortes Barrantes (PC)

From the David G. Cogan Laboratory of Ophthalmic Pathology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA.

Eva DeVience (E)

Department of Ophthalmology, West Virginia University, Morgantown, West Virginia USA.

Bilal A Rana (BA)

Department of Ophthalmology, West Virginia University, Morgantown, West Virginia USA.

Nupur Jadhav (N)

Baystate, Department of Pathology, University of Massachusetts Medical School, Wooster, Massachusetts USA.

Kymberly Gyure (K)

Department of Pathology, Allegheny Health Network, Pittsburgh, Pennsylvania USA.

Hans E Grossniklaus (HE)

Department of Ophthalmology, Emory University, Atlanta, Georgia USA.

Bradley A Thuro (BA)

Department of Ophthalmology, West Virginia University, Morgantown, West Virginia USA.

Jean Henneberry (J)

Baystate, Department of Pathology, University of Massachusetts Medical School, Wooster, Massachusetts USA.

Tatyana Milman (T)

Department of Pathology, Wills Eye Hospital, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania USA.

Ralph C Eagle (RC)

Department of Pathology, Wills Eye Hospital, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania USA.

Carol L Shields (CL)

Ocular Oncology Service, Wills Eye Hospital, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania.

Jerry A Shields (JA)

Ocular Oncology Service, Wills Eye Hospital, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania.

Thaddeus P Dryja (TP)

From the David G. Cogan Laboratory of Ophthalmic Pathology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH